Pamela Vig
Chief Tech/Sci/R&D Officer at MIRUM PHARMACEUTICALS, INC.
Net worth: 3 M $ as of 2024-03-30
Profile
Pamela Vig is currently the Chief Scientific Officer & Head-Research at Mirum Pharmaceuticals, Inc. She previously worked as the Director-Clinical Development at Shire ViroPharma, Inc., Associate Director-European Medical Affairs at Idenix Pharmaceuticals LLC, Director-Global Medical Affairs at Johnson & Johnson Ltd., Clinical Research Officer at Chiron Corp.
and Gilead Sciences, Inc., Associate VP-Clinical Research & Development at Presidio Pharmaceuticals, Inc. and Allergan Ltd.
(Ireland), Vice President-Clinical Research & Discovery at Tobira Therapeutics, Inc., and Chief Scientific Officer at Flashlight Therapeutics, Inc. Dr. Vig obtained her graduate and doctorate degrees from Imperial College London and her undergraduate degree from the University of Nevada.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-02-01 | 103,691 ( 0.22% ) | 3 M $ | 2024-03-30 |
Pamela Vig active positions
Companies | Position | Start |
---|---|---|
MIRUM PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2018-11-30 |
Former positions of Pamela Vig
Companies | Position | End |
---|---|---|
ALLERGAN PLC | Corporate Officer/Principal | 2017-10-31 |
TOBIRA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 2016-10-31 |
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 2015-06-30 |
Johnson & Johnson Ltd.
Johnson & Johnson Ltd. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Ltd. is a British company that manufactures health care products. The private company is based in Maidenhead, UK. Founded in 1987. | Corporate Officer/Principal | - |
Flashlight Therapeutics, Inc.
Flashlight Therapeutics, Inc. BiotechnologyHealth Technology Flashlight Therapeutics, Inc. develops therapeutics for unmet medical needs. | Chief Tech/Sci/R&D Officer | - |
Training of Pamela Vig
Imperial College London | Doctorate Degree |
University of Nevada | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
MIRUM PHARMACEUTICALS, INC. | Health Technology |
Private companies | 8 |
---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Chiron Corp. provides nucleic acid test for blood screening. Its products include tigris system, target capture system, reagent preparation incubator, and many more. The company was founded in 1981 by William J. Rutter, Edward E. Penhoet & Pablo Valenzuela and is headquartered in Emeryville, CA. | Health Technology |
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
Johnson & Johnson Ltd.
Johnson & Johnson Ltd. Household/Personal CareConsumer Non-Durables Part of Kenvue, Inc., Johnson & Johnson Ltd. is a British company that manufactures health care products. The private company is based in Maidenhead, UK. Founded in 1987. | Consumer Non-Durables |
Presidio Pharmaceuticals, Inc.
Presidio Pharmaceuticals, Inc. BiotechnologyHealth Technology Presidio Pharmaceuticals, Inc. discovers and develops small-molecule antiviral therapeutics. Its products in pipeline include NS5A, PPI-668 and PPI-383 for treating hepatitis C virus infections. The company was founded by Omar K. Haffar, Antoun Nabhan and David V. Jobes in March 2006 and is headquartered in San Francisco, CA. | Health Technology |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Tobira Therapeutics, Inc.
Tobira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded on October 6, 2006 and is headquartered in Madison, NJ. | Health Technology |
Flashlight Therapeutics, Inc.
Flashlight Therapeutics, Inc. BiotechnologyHealth Technology Flashlight Therapeutics, Inc. develops therapeutics for unmet medical needs. | Health Technology |
- Stock Market
- Insiders
- Pamela Vig